abstract |
The present invention relates to a covalent complex of von Willebrand Factor (VWF) and Factor VIII, wherein the complex is modified to have an extended half-life in vivo. The invention further relates to a method of making the complex and to the use of the complex for the treatment or prevention of a bleeding event. |